Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristin L M Boylan

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Genetics|November 28, 2002
The gene for the intermediate chain subunit of cytoplasmic dynein is essential in DrosophilaKristin L M Boylan, Thomas S Hays
Cryobiology|January 29, 2013
Isothermal vitrification methodology development for non-cryogenic storage of archival human seraRebekah Less, Kristin L M Boylan, Amy P N Skubitz, et al.
Cancers|March 13, 2025
A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients' AscitesKristin L M Boylan, Caitlin Walz, Alexandra M Schefter, et al.
Cancer Informatics|November 16, 2011
Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancerJason B Nikas, Kristin L M Boylan, Amy P N Skubitz, et al.
International Journal of Molecular Sciences|July 8, 2020
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4Kristin L M Boylan, Rory D Manion, Heena Shah, et al.
Plos Genetics|February 20, 2008
Motility screen identifies Drosophila IGF-II mRNA-binding protein--zipcode-binding protein acting in oogenesis and synaptogenesisKristin L M Boylan, Sarah Mische, Mingang Li, et al.
Journal of Proteome Research|July 11, 2026
Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle TechnologyCarly A I Twigg, Kathleen M Madden, Kristin L M Boylan, et al.
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Clinical Proteomics|October 21, 2017
A multiplex platform for the identification of ovarian cancer biomarkersKristin L M Boylan, Kate Geschwind, Joseph S Koopmeiners, et al.
Clinical Proteomics|January 8, 2021
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomicsKristin L M Boylan, Somaieh Afiuni-Zadeh, Melissa A Geller, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Genetics|November 28, 2002
The gene for the intermediate chain subunit of cytoplasmic dynein is essential in DrosophilaKristin L M Boylan, Thomas S Hays
Cryobiology|January 29, 2013
Isothermal vitrification methodology development for non-cryogenic storage of archival human seraRebekah Less, Kristin L M Boylan, Amy P N Skubitz, et al.
Cancers|March 13, 2025
A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients' AscitesKristin L M Boylan, Caitlin Walz, Alexandra M Schefter, et al.
Cancer Informatics|November 16, 2011
Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancerJason B Nikas, Kristin L M Boylan, Amy P N Skubitz, et al.
International Journal of Molecular Sciences|July 8, 2020
Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4Kristin L M Boylan, Rory D Manion, Heena Shah, et al.
Plos Genetics|February 20, 2008
Motility screen identifies Drosophila IGF-II mRNA-binding protein--zipcode-binding protein acting in oogenesis and synaptogenesisKristin L M Boylan, Sarah Mische, Mingang Li, et al.
Journal of Proteome Research|July 11, 2026
Protein Enrichment from Ascites Fluid Using Nanotrap Hydrogel Particle TechnologyCarly A I Twigg, Kathleen M Madden, Kristin L M Boylan, et al.
Clinical Proteomics|January 3, 2024
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assayJoohyun Ryu, Kristin L M Boylan, Carly A I Twigg, et al.
Clinical Proteomics|October 21, 2017
A multiplex platform for the identification of ovarian cancer biomarkersKristin L M Boylan, Kate Geschwind, Joseph S Koopmeiners, et al.
Clinical Proteomics|January 8, 2021
Evaluation of the potential of Pap test fluid and cervical swabs to serve as clinical diagnostic biospecimens for the detection of ovarian cancer by mass spectrometry-based proteomicsKristin L M Boylan, Somaieh Afiuni-Zadeh, Melissa A Geller, et al.
Pageof 3